January 3, 2022
New publication shows beneficial effect of lactulose when compared to other laxatives
read moreSeptember 27, 2021
Galactofructose f-Type – A new upcycled functional ingredient for food and feed application developed by Fresenius Kabi
read moreJune 17, 2021
New study confirms blood glucose levels of type 2 diabetic patients are not affected after oral Lactulose intake
read moreMay 12, 2021
Lactulose in vitro study shows effects on microbiota
read moreFebruary 6, 2020
Seal of Approval for Workplace Health Promotion
read moreJanuary 30, 2020
CPhI Milano 13.10.2020 until 15.10.2020 - provisional booth #14F10 in hall H14
read moreJanuary 21, 2020
Our new Brand Website is online - www.laevolac.com
read moreOctober 23, 2018
CPhI Frankfurt 05.11.2019 until 07.11.2019 / booth # 6.0B31
read moreOctober 23, 2018
CPhI Madrid 2018 - Thank you for your visit!
read moreOctober 11, 2018
Vitafoods Europe - 07.05.2019 until 09.05.2019 / booth # M76
read moreContact
Fresenius Kabi Austria GmbH
Branch Linz
Estermannstraße 17
4020 Linz
Austria
Tel.: +43 732 7651 0
Fax.: +43 732 7651 2330
email: international.linz@fresenius-kabi.at
Congresses